Solid Biosciences

Traded on the St. Petersburg Stock Exchange
Solid Biosciences is an American biopharmaceutical company, engages in developing therapies for duchenne muscular dystrophy (DMD). It was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
Solid Biosciences stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Solid Biosciences balance sheet

Report period2018 2019 2020 2021 2022 Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Solid Biosciences cash flows

Report period2018 2019 2020 2021 2022 Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Solid Biosciences multipliers

Report period2018 2019 2020 2021 2022 Q3 23 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Solid Biosciences profitability

Report period2018 2019 2020 2021 2022 Q3 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Solid Biosciences assets
Solid Biosciences cash flows

Solid Biosciences dividend policy

The company doesn't provide dividends

Solid Biosciences shares

TickerNameTypeNominal valueISINPrice
SLDB:USSolid BiosciencesCommon share-US83422E1055$5.77
Solid Biosciences news
27.04.2022
Solid Biosciences' GAAP loss for 3 months of 2022 was $25.328 million, up 49.9% from $16.9 million in the previous year. Revenue decreased 42.3% to $1,925 million from $3,335 million a year earlier.
Source: {source} pictogram investors.solidbio.com
Pictogram next
04.11.2021
Solid Biosciences' GAAP loss for 9M 2021 was $53.578 million, down 19.9% from $66.927 million in the previous year. Revenues were $10.466 million. The company did not generate revenues a year earlier.
Source: {source} pictogram investors.solidbio.com
Pictogram next
All Solid Biosciences news
General information
Company nameSolid Biosciences
Tags#biotechnology, #pharmacy
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address141 Portland Street Fifth Floor Cambridge, MA 02139 United States
Mailing address141 Portland Street Fifth Floor Cambridge, MA 02139 United States
Websiteinvestors.solidbio.com